CNY 12.66
(0.88%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.97 Billion | 799.97 Million | 1.6 Billion | 1.93 Billion | 2.78 Billion | 3.33 Billion |
Net Income | 366.55 Million | 685.05 Million | 1.31 Billion | 1.01 Billion | 1.29 Billion | 2.83 Billion |
Depreciation & Amortization | 3.49 Billion | 2.94 Billion | 2.11 Billion | 1.77 Billion | 1.61 Billion | 1.43 Billion |
Deferred income taxes | 13.29 Million | -10.46 Million | 35.97 Million | -83.74 Million | -24.51 Million | -10.17 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -654.61 Million | -3.81 Billion | -2.38 Billion | -1.37 Billion | -571.1 Million | -1.27 Billion |
Other non-cash items | 446.38 Million | 963.76 Million | 571.15 Million | 521.31 Million | 451.57 Million | 342.35 Million |
Investing Cash Flow | -2.68 Billion | -4.1 Billion | -8.6 Billion | -4.57 Billion | -1.57 Billion | -4.92 Billion |
Investments in PPE | -2.49 Billion | -4.09 Billion | -8.52 Billion | -4.21 Billion | -2.99 Billion | -5.29 Billion |
Acquisitions | 209.69 Million | 60.18 Million | 69.44 Million | -361.44 Million | 13.73 Million | 10.5 Million |
Investment purchases | -430.08 Million | -196.46 Million | -155.56 Million | -13.86 Million | -101.28 Million | -156 Million |
Sales/Maturities of investments | 28.45 Million | 124.71 Million | -69.44 Million | 4.23 Billion | 52.9 Million | 461.8 Million |
Other Investing Activities | -191.94 Million | 0.31 | 69.44 Million | -4.21 Billion | 1.46 Billion | 53.77 Million |
Financing Cash Flow | -1.82 Billion | 9.88 Billion | 2.19 Billion | 7.56 Billion | -3.72 Billion | 992.99 Million |
Debt repayment | -1.51 Billion | -4.49 Billion | -1.75 Billion | -1.69 Billion | -3.83 Billion | -425 Million |
Dividends payments | -247.55 Million | -444.14 Million | -671.9 Million | -405.39 Million | -810.78 Million | -1.1 Billion |
Common Stock Repurchased | -419.12 Million | -700.03 Million | - | -350 Million | - | -349.99 Million |
Common Stock Issuance | - | -3.81 Million | - | 321.22 Million | - | - |
Other Financing Activities | 252.04 Million | 15.85 Billion | 4.8 Billion | 9.8 Billion | 1.08 Billion | 2.52 Billion |
Accounts receivables | -340.81 Million | -299.52 Million | -1.2 Billion | 487.78 Million | 165.86 Million | -644.59 Million |
Accounts payables | -473.02 Million | -1.73 Billion | -706.58 Million | -687.38 Million | -127.31 Million | 371.26 Million |
Inventory | 145.92 Million | -1.76 Billion | -508.47 Million | -1.09 Billion | -585.14 Million | -988.57 Million |
Other working capital | -459.73 Million | -10.46 Million | 35.97 Million | -83.74 Million | -24.51 Million | -283.5 Million |
Cash at beginning of period | 8.26 Billion | 1.66 Billion | 6.51 Billion | 1.6 Billion | 4.1 Billion | 4.68 Billion |
Cash at end of period | 7.75 Billion | 8.26 Billion | 1.66 Billion | 6.51 Billion | 1.6 Billion | 4.1 Billion |
Capital Expenditure | -2.49 Billion | -4.09 Billion | -8.52 Billion | -4.21 Billion | -2.99 Billion | -5.29 Billion |
Effect of forex changes on cash | 15.03 Million | 17.8 Million | -37.7 Million | -12.29 Million | 4.21 Million | 18.9 Million |
Net cash flow / Change in cash | -514.19 Million | 6.59 Billion | -4.84 Billion | 4.91 Billion | -2.5 Billion | -575.04 Million |
Free Cash Flow | 1.48 Billion | -3.29 Billion | -6.91 Billion | -2.28 Billion | -208.17 Million | -1.95 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 62.87 Million | 65.55 Million | 118.74 Million | 193.96 Million | 366.55 Million | 2.64 Million |
Depreciation & Amortization | - | 949.79 Million | 949.79 Million | 941.78 Million | 3.49 Billion | -1.68 Billion |
Deferred income taxes | - | - | - | - | 13.29 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -194.88 Million | -654.61 Million | 448.06 Million |
Other non-cash items | 598.02 Million | 1.87 Billion | 422.24 Million | 3.04 Billion | 446.38 Million | 1.64 Billion |
Investing Cash Flow | -1.58 Billion | -657.52 Million | -477.77 Million | -648.25 Million | -2.68 Billion | -647.84 Million |
Investments in PPE | -879.92 Million | -669.01 Million | -516.46 Million | -392.56 Million | -2.49 Billion | -707.42 Million |
Acquisitions | 31.26 Million | 5.25 Million | 38.69 Million | 92.66 Million | 209.69 Million | 115.58 Million |
Investment purchases | -741.2 Million | - | - | -359.08 Million | -430.08 Million | -56 Million |
Sales/Maturities of investments | 3.18 Million | 6.23 Million | - | 10.73 Million | 28.45 Million | -115.58 Million |
Other Investing Activities | - | 11.48 Million | 38.69 Million | -255.69 Million | -191.94 Million | 115.58 Million |
Financing Cash Flow | 708.44 Million | -928 Million | 340.78 Million | -1.23 Billion | -1.82 Billion | -149.27 Million |
Debt repayment | -1.11 Billion | -79.51 Million | -1.58 Billion | -598.25 Million | -1.51 Billion | -1.28 Billion |
Dividends payments | - | -221.23 Million | -69.75 Million | -247.55 Million | -247.55 Million | -322.71 Million |
Common Stock Repurchased | - | - | - | -419.12 Million | -419.12 Million | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -405.71 Million | -848.21 Million | -1.17 Billion | -558.2 Million | 252.04 Million | 1.45 Billion |
Accounts receivables | - | - | - | -340.81 Million | -340.81 Million | -22.89 Million |
Accounts payables | - | - | - | - | -473.02 Million | - |
Inventory | - | - | - | 145.92 Million | 145.92 Million | 470.96 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 8.9 Billion | 9.28 Billion | 7.75 Billion | 7.35 Billion | 8.26 Billion | 7.74 Billion |
Cash at end of period | 8.89 Billion | 8.9 Billion | 8.15 Billion | 7.75 Billion | 7.75 Billion | 7.35 Billion |
Capital Expenditure | -879.92 Million | -669.01 Million | -516.46 Million | -392.56 Million | -2.49 Billion | -707.42 Million |
Effect of forex changes on cash | - | 6.63 Million | -2 Million | -4.72 Million | 15.03 Million | -1.37 Million |
Net cash flow / Change in cash | -4.87 Million | -380.34 Million | 401.99 Million | 396.23 Million | -514.19 Million | -384.71 Million |
Free Cash Flow | -219.03 Million | 325.77 Million | 24.52 Million | 1.9 Billion | 1.48 Billion | -293.65 Million |
8960
ORCHPHARMA
SKHCF
NIKL
008930
ZOREN